Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Whole Blood Transfusion for TBI
NCT06184828Phase 3Not yet recruiting
- Sponsor
- Oregon Health & Science University
- Start
- Aug 2024
- Primary completion
- Sep 2025
- Modality
- Tissue Cells
01
Overview
A Phase 3 trial of low-titer group O whole blood in traumatic brain injury (TBI), sponsored by Oregon Health & Science University. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
low-titer group O whole blood
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT06184828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06184828.